Press "Enter" to skip to content

BIG TECH, BIG MEDIA, BIG MONEY: Full Circle to the D.C. Swamp Part II – Political Contributions by BlackRock and Vanguard

In this article: Examining political contributions to further understand how the generational political continuum including our list of Flynn, Russia, Mueller, Ukraine, impeachment 1.0, COVID-19, the stolen 2020 election, the Capitol “insurrection” event and impeachment 2.0 is patently and abjectly demonstrable as FRAUD as much as it is sedition and treason; and it all appears to have been funded by BlackRock and Vanguard - BIG TECH, BIG MEDIA & BIG MONEY.

IT’S ALL ENTERPRISE FRAUD, EVERY BIT OF IT: Trump, Clinton, COVID-19, BlackRock, Vanguard and All of the Pieces In Between

An important and substantial article taking two recent developments - Trump's fraud filing against Clinton and a BlackRock/Vanguard article from Conservative Treehouse - to augment and entire slate of evidenced and existing positions delineating the enterprise fraud accountable for the geopolitical status quo delivered by The Biden Crime Family.

BRIEF: The Advisory Committee on Immunization Practices [ACIP] and Its Exposure, Culpability and Liability for Adverse “Vaccine” Injury and Death

The purpose of this non-journalistic and technical brief is to: 1-Identify the relevant statutes, agencies, departments and individuals that bear the duty to provide advice and guidance to the Director of the CDC regarding use of vaccines and related agents for effective control of vaccine-preventable diseases in the civilian population of the United States, 2-Identify vectors for litigation against those agencies, departments and individuals, 3-To assist and lend assistance to an individuals, families and their attorneys pursuing litigation for adverse reactions up to death caused by mRNA injections for COVID-19.

FURTHER EVIDENCE THAT PATENTS AND PATENT-SHARING ARE ENTIRELY RELEVANT TO THE CORONAVIRUS

(FOURTH article in a series) With firm evidence that George Soros, Gilead Sciences and UNITAID desired to penetrate China's closed pharmaceutical market with patent-sharing strategies, additional evidence emerges on a coronavirus patent holder.